Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-01

Clinical Trial Update: Study to Establish Image Interpretation Criteria for 18F Fluciclovine PET in Detecting Recurrent Brain Metastases (PURSUE) [Phase 2]

View source ↗

Summary

Phase 2 study PURSUE has completed and its results have been posted. It aims to establish image interpretation criteria for 18F-fluciclovine PET in detecting re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Axumin (fluciclovine F-18)

Snippet

Sponsor: Blue Earth Diagnostics | Conditions: Brain Metastases | Phase 2 | Status: COMPLETED | Results posted: 2023-08-01